84.48

1.68% -1.44

After Hours: 84.48

Billiontoone Inc (BLLN)

Overview News Price History Discussions Forecast

Billiontoone Inc stock is traded at $84.48, with a volume of 699.01K. It is down -1.68% in the last 24 hours and down -0.31% over the past month. BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Previous Close:

$85.92

Open:

$86.6

24h Volume:

699.01K

Relative Volume:

1.45

Market Cap:

$3.89B

Revenue:

$305.11M

Net Income/Loss:

$-196.00K

P/E Ratio:

-12,996.92

EPS:

-0.0065

Net Cash Flow:

1W Performance:

+2.66%

1M Performance:

-0.31%

6M Performance:

-33.92%

1Y Performance:

+0.00%

1-Day Range:

$80.27

$86.60

1-Week Range:

$78.01

$87.87

52-Week Range:

$61.96

$138.70

Billiontoone Inc Stock (BLLN) Company Profile

Name

Billiontoone Inc

Sector

Healthcare (1111)

Industry

Diagnostics & Research (52)

Phone

650-460-2551

Address

1035 O'BRIEN DRIVE, MENLO PARK

Employee

713

Twitter

Next Earnings Date

2026-05-06

Latest SEC Filings

BLLN's Discussions on Twitter

Compare BLLN vs TMO, DHR, IDXX, WAT, A

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BLLN Billiontoone Inc	84.48	3.95B	305.11M	-196.00K	0	-0.0065
TMO Thermo Fisher Scientific Inc	448.18	166.59B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	172.81	121.74B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	557.21	44.12B	4.45B	1.10B	1.06B	13.59
WAT Waters Corp	338.64	33.62B	3.77B	449.25M	240.68M	7.8556
A Agilent Technologies Inc	115.08	32.49B	7.07B	1.29B	993.00M	4.5355

Billiontoone Inc Stock (BLLN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-06-26	Initiated	Guggenheim	Buy
Dec-01-25	Initiated	BTIG Research	Buy
Dec-01-25	Initiated	JP Morgan	Overweight
Dec-01-25	Initiated	Jefferies	Hold
Dec-01-25	Initiated	Piper Sandler	Overweight
Dec-01-25	Initiated	Stifel	Buy
Dec-01-25	Initiated	Wells Fargo	Equal Weight
Dec-01-25	Initiated	William Blair	Outperform

View All

Billiontoone Inc Stock (BLLN) Latest News

May 25, 2026

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), BillionToOne, Inc. Class A (BLLN) and Solventum Corporation (SOLV) - The Globe and Mail

May 25, 2026

Does BillionToOne (BLLN) Have the Potential to Rally 37% as Wall Street Analysts Expect? - Zacks Investment Research

May 25, 2026

May 22, 2026

Top Billiontoone (BLLN) Competitors 2026 - MarketBeat

May 22, 2026

Transcript : BillionToOne, Inc., Q1 2026 Earnings Call, May 06, 2026 - marketscreener.com

May 22, 2026

May 21, 2026

BLLN Technical Analysis | Trend, Signals & Chart Patterns | BILLIONTOONE INC CL A (NASDAQ:BLLN) - ChartMill

May 21, 2026

May 20, 2026

BillionToOneStarting 2026 Strong (NASDAQ:BLLN) - Seeking Alpha

May 20, 2026

BLLN Stock Price, Quote & Chart | BILLIONTOONE INC CL A (NASDAQ:BLLN) - ChartMill

May 20, 2026

May 17, 2026

Jim Cramer on BillionToOne: “I Say Buy It” - Insider Monkey

May 17, 2026

May 15, 2026

BillionToOne Launches Non-Invasive Prenatal Confirmation Test Using Fetal Cells - Clinical Lab Products

May 15, 2026

BillionToOne's (NASDAQ:BLLN) Strong Earnings Are Of Good Quality - 富途牛牛

May 15, 2026

Cramer: Design Therapeutics Is ‘Pure Spec,’ Buy This Health Care StockBillionToOne (NASDAQ:BLLN), Desi - Benzinga

May 15, 2026

Jim Cramer: Design Therapeutics Is 'Pure Spec,' Buy This Health Care Stock - Sahm

May 15, 2026

May 14, 2026

Cramer's lightning round: Buy BillionToOne - MSN

May 14, 2026

May 13, 2026

BillionToOne (NASDAQ:BLLN) Momentum Fuels Nasdaq Healthcare Interest - Kalkine Media

May 13, 2026

BillionToOne (BLLN) NeoTribe funds shift 465,607 shares in internal move - Stock Titan

May 13, 2026

Fund and trust transfers reshape BillionToOne (BLLN) share stake - Stock Titan

May 13, 2026

Guggenheim Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $120 - Moomoo

May 13, 2026

Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year? - Yahoo Finance

May 13, 2026

BillionToOne's (NASDAQ:BLLN) Earnings May Just Be The Starting Point - simplywall.st

May 13, 2026

Solid Earnings Reflect BillionToOne's (NASDAQ:BLLN) Strength As A Business - Yahoo Finance

May 13, 2026

Guggenheim raises BillionToOne stock price target to $120 on reimbursement progress - Investing.com Nigeria

May 13, 2026

Guggenheim raises BillionToOne stock price target to $120 on reimbursement progress By Investing.com - Investing.com South Africa

May 13, 2026

BillionToOne Q1 2026 slides: 84% revenue surge, GAAP profitability By Investing.com - Investing.com South Africa

May 13, 2026

May 12, 2026

Why BillionToOne Stock Is Suddenly Sliding - TipRanks

May 12, 2026

BillionToOne Q1 2026 slides: 84% revenue surge, GAAP profitability - Investing.com

May 12, 2026

Earnings call transcript: BillionToOne Q1 2026 earnings surge, stock jumps - Investing.com

May 12, 2026

Earnings call transcript: BillionToOne Q1 2026 earnings surge, stock jumps By Investing.com - Investing.com Nigeria

May 12, 2026

Wall Street analysts predict a 25.63% upside in BillionToOne (BLLN): Here's what you should know - MSN

May 10, 2026

May 09, 2026

Discover May 2026's Top Stocks Estimated Below Intrinsic Value - Sahm

May 09, 2026

AI Model Lifts Score on BillionToOne (BLLN) After Earnings Turnaround - TipRanks

May 09, 2026

May 08, 2026

Number of shareholders of BillionToOne, Inc. – NASDAQ:BLLN - TradingView

May 08, 2026